Skip to main content
Log in

A Heterogeneous Tube Model of Intestinal Drug Absorption Based on Probabilistic Concepts

  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

Purpose. To develop an approach based on computer simulations for the study of intestinal drug absorption.

Methods. The drug flow in the gastrointestinal tract was simulated with a biased random walk model in the heterogeneous tube model Pharm. Res. 16, 87-91, 1999), while probability concepts were used to describe the dissolution and absorption processes. An amount of drug was placed into the input end of the tube and allowed to flow, dissolve and absorb along the tube. Various drugs with a diversity in dissolution and permeability characteristics were considered. The fraction of dose absorbed (F abs ) was monitored as a function of time measured in Monte Carlo steps (MCS). The absorption number An was calculated from the mean intestinal transit time and the absorption rate constant adhering to each of the drugs examined.

Results. A correspondence between the probability factor used to simulate drug absorption and the conventional absorption rate constant derived from the analysis of data was established. For freely soluble drugs, the estimates for F abs derived from simulations using as an intestinal transit time 24500 MCS (equivalent to 4.5 h) were in accord with the corresponding data obtained from literature. For sparingly soluble drugs, a comparison of the normalized concentration profiles in the tube derived from the heterogeneous tube model and the classical macroscopic mass balance approach enabled the estimation of the dissolution probability factor for five drugs examined. The prediction of F abs can be accomplished using estimates for the absorption and the dissolution probability factors.

Conclusions. A fully computerized approach which describes the flow, dissolution and absorption of drug in the gastrointestinal tract in terms of probability concepts was developed. This approach can be used to predict F abs for drugs with various solubility and permeability characteristics provided that probability factors for dissolution and absorption are available.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. J. B. Dressman, G. L. Amidon, and D. Fleisher. Absorption potential: estimating the fraction absorbed for orally administered compounds. J. Pharm. Sci. 74:588–589 (1985).

    Google Scholar 

  2. J. B. Dressman and D. Fleisher. Mixing-tank model for predicting dissolution rate control of oral absorption. J. Pharm. Sci. 75:109–116 (1986).

    Google Scholar 

  3. P. Macheras and M. Symillides. Toward a quantitative approach for the prediction of the fraction of dose absorbed using the absorption potential concept. Biopharm. Drug Dispos. 10:43–53 (1989).

    Google Scholar 

  4. P. J. Sinko, G. D. Leesman, and G. L. Amidon. Predicting fraction dose absorbed in humans using a macroscopic mass balance approach. Pharm. Res. 8:979–988 (1991).

    Google Scholar 

  5. D.-M. Oh, R. L. Curl, and G. L. Amidon. Estimating the fraction dose absorbed from suspensions of poorly soluble compounds in humans: a mathematical model. Pharm. Res. 10:264–270 (1993).

    Google Scholar 

  6. L. X. Yu, E. Lipka, J. R. Crison, and G. L. Amidon. Transport approaches to the biopharmaceutical design of oral drug delivery systems: prediction of intestinal absorption. Adv. Drug Del. Rev. 19:359–376 (1996).

    Google Scholar 

  7. L. X. Yu and G. L. Amidon. Saturable small intestinal drug absorption in humans: modeling and interpretation of cefatrizine data. Eur. J. Pharm. Biopharm. 45:199–203 (1998).

    Google Scholar 

  8. G. L. Amidon, H. Lennernas, V. P. Shah, and J. R. Crison. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm. Res. 12:413–420 (1995).

    Google Scholar 

  9. P. Macheras and P. Argyrakis. Gastrointestinal drug absorption: Is it time to consider heterogeneity as well as homogeneity? Pharm. Res. 14:842–847 (1997).

    Google Scholar 

  10. A. Kalampokis, P. Argyrakis, and P. Macheras. A heterogeneous tube model for the study of the small intestinal transit flow. Pharm. Res. 16:87–91 (1999).

    Google Scholar 

  11. M. Fegertholm, Johansson, and H. Lennernas. Comparison between permeability coefficients in rat and human jejunum. Pharm. Res. 13:1336–1341 (1996).

    Google Scholar 

  12. L. X. Yu, J. Crison, and G. L. Amidon. Compartmental transit and dispersion model analysis of small intestinal transit flow in humans. Int. J. Pharm. 140:111–118 (1996).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Panos Macheras.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kalampokis, A., Argyrakis, P. & Macheras, P. A Heterogeneous Tube Model of Intestinal Drug Absorption Based on Probabilistic Concepts. Pharm Res 16, 1764–1769 (1999). https://doi.org/10.1023/A:1018918402237

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1018918402237

Navigation